中国美容医学2017年10月第26卷第10期ChineseJournalofAestheticMedicine.Oct.2017.Vol.26.No.10
87
[32]
Surg,2002,110(2):560-571.
注射液治疗相关疾病，宗宪磊等使用曲安奈德与复方倍
[16]ParkTH,SeoSW,KimJK,eta1.Clinicalcharacteristicsoffacial
他米松注射液治疗瘢痕疙瘩，均发现两种药物有协同作用。
keloidstreatedwithsurgicalexcisionfollowedbyintra-and
临床上，笔者根据瘢痕疙瘩不同部位、不同程度等采用手术
postoperativeintralesionalsteroidinjections[J].AestheticPlast
加注射、局部注射加外用药物、局部注射加局部加压等个性
Surg,2012,36(1):169-173.
化治疗方案。选择就诊患者中经济承受能力较差，时间较为
[17]DarziMA,ChowdriNA,KaulSK,eta1.Evaluationofvarious
紧张的瘢痕疙瘩患者入选为本组研究对象，采用综合治疗模methodsoftreatingkeloidsandhypertrophicscarsa10-yearfollow-
upstudy[J].BrJPlastSurg,1992,45(5):374-379.
式，痊愈39例，显效19例，有效8例，无效4例，总有效率为
[18]WilsonAM.Eradicationofkeloids:Surgicalexcisionfollowed
94.3%。并发症发生情况，痤疮生长2例，毛发生长1例，肥
byasingleinjectionofintralesional5-fluorouracilandbotulinum
胖1例，总不良反应发生率为5.7%，结果显示疗效显著。
toxin[J].CanJPlastSurg,2013,21:87-91.
综上，运用复方倍他米松注射液联合曲安奈德注射液
[19]DaroughehA,AsilianA,ShariatiF.Intralesionaltriamcinolonealone
序贯治疗瘢痕疙瘩，具有费用低、恢复快、依从性好、疗
orincombinationwith5-Fluorouracilforthetreatmentofkeloidand
hypertrophicscars[J].ClinExpDermatol,2009,34(2):219-223.
效佳、不良反应较低、复发率较低、安全性高，患者更容
[20]KontochristopoulosG,StefanakiC,PanagiotopoulosA,et
易接受等实用性优点，值得在临床上推广应用。
a1.Intralesional5-fluorouracilinthetreatmentofkeloidsanopen
clinicalandhistopathologicstudy[J].JAmAcadDermatol,2005,52(3
[参考文献]
Pt1):474-479.
[1]EoffaMJ.Methotrexateforpsoriasis:currentEuropeanpractice.
[21]KieranI,KnockA,BushJ,eta1.Interleukin-lOreducesscar
Apostasurvey[J].EurAcadDermatolVenereol,2005,19(7):196.
formationinbothanimalandhumancutaneouswounds:resultsof
[2]蔡景龙.瘢痕整形美容外科学[M].浙江:浙江科学技术出版
twopreclinicalandphaseⅡradomizedcontrolstudies[J].Wound
社,2015:758-774.
RepairRegen,2013,21(3):428-436.
[3]丁勇,严雪琴,邵加文,等.126例瘢痕疙瘩的治疗分析[J].中国医
[22]RobinsonAJ,KhadimMF,KhanK.Keloidscarsandtreatmentwith
2013,11(4):146-147.
药指南,
BotulinumToxinTypeA:theBelfastexperience[J].JPlastReconstr
[4]BermanB,BieleyHC.Adjuncttherapiestosurgicalmanagementof
AesthetSurg,2013,66(3):439-440.
keloids[J].DermatolSurg,1996,22(2):126-l30.
[23]WolframD,TzankovA,PulzlP,eta1.Hypertrophicscarsand
[5]BrodyGS.Keloidsandhypertrophicscars[J].PlastReconstr
keloids-areviewoftheirpathophysiology,riskfactors,andtherapeutic
Surg,1990,86(4):804.
management[J].DermatolSurg,2009,35(2):171-181.
[6]AnnacontiniL,ParisiD,MaiorellaA,eta1.Long-termfollow-up
[24]GuptaS,SharmaVK.StandardguidelinesofcareKeloids
inthetreatmentofkeloidsbycombinedsurgicalexcisionand
andhypertrophicscars[J].IndianJDermatolVenereol
immediatepostoperativeadjuvantradiation[J].PlastReconstri
Leprol,2011,77(1):94-100.
Surg,2008,12l(2):700-701.
[25]HuangC,MurphyGF,AkaishiS,etal.Keloidsandhypertrophic
[7]刘宁,黄金龙,刘育凤.保留瘢痕组织瓣的耳廓瘢痕疙瘩切除[J].
Scars:updateandfuturedirections[J].PlastReconstrSurgGlob
临床耳鼻咽喉头颈外科杂志,2014,28(13):990-991.
Open,2013,1(4):25.
[8]KellyAP.Updateonthemanagementofkeloids[J].SeminCutanMed
[26]NaylorMC,brissettAE.Currentconceptsintheetiologyand
Surg,2009,28(2):71-76.
treatmentofkeloids[J].FacialPlastSurg,2012,28(5):504-512.
[9]OgawaR,YoshitatsuS,YoshidaK,eta1.Isradiationtherapyfor
[27][J]
郭果香,刘慧焕,辛燕.瘢痕疙瘩的治疗现状.中国冶金工业医
keloidsacceptable?Theriskofradiation-inducedcarcinogenesis[J].
学杂志,2013,30(4):407-408.
PlastReconstrSurg,2009,124(4):1196-1201.
[28]KalHB,VeenRE,Jurgenliemk-SchulzIM.Dose-effectrelationships
[10]CassutoDA,ScrimaliL,SiragoP.Treatmentofhypertrophicscars
forrecurrenceofkeloidandpterygiumaftersurgeryand
andkeloidswithanLBOlaser(532am)andsiliconegelsheeting[J].J
radiotherapy[J].IntRadiatOncolBiolPhys,2009,74(1):245-251.
CosmetLaserTher,2010,12(1):32-37.
[29]林小龙,吕海苓,何曦.术后药物注射与放射治疗耳部瘢痕疙瘩
[11]GoldMH.Acontrolledclinicaltrialoftopicalsiliconegelsheeting
[J].2015,24(21):2334-2336.
的效果分析现代中西医结合杂志,
inthetreatmentofhypertrophicscarsandkeloids[J].JAmAcad
[30]HochmanB,LocaliRF,MatsuokaPK,etal.Intralesionaltriamcinolo
Dermat,1994,30(3):506-507.
neacetonideforkeloidtreatment:asysthematicreview[J].Aesthetic
[12]柯丹,刁庆春.瘢痕疙瘩物理治疗研究进展[J].重庆医
PlastSurg,2008,32(4):705-709.
,2008,37(16):1856-1858.
学
[31]文海鹏.曲安奈德与复方倍他米松注射液对椎间盘突出症患者
[13]Al-AttarA,MessS,ThomassenJM,eta1.Keloidpathogenesisand
疼痛的治疗作用研究[J].医学信息,2011,7:3095-3096.
treatment[J].PlastReconstrSurg,2006,117(1):286-300.
[32]宗宪磊,宋国栋,都乐,等.曲安奈德联合德宝松注射液治疗瘢痕
[14][J]
陈敏燕,潘九英,金芝贵,等.药物治疗瘢痕疙瘩的应用研究.
[J],2016,13(6):55-58
疙瘩效果.中国医药导报．
药学服务与研究,2010,l0(1):55-58．
[15]MustoeTA,CooterRD,GoldMH,eta1.Internationalclinical
[收稿日期]2017-05-09[修回日期]2017-06-20
recommendationsonscarmanagement[J].PlastReconstr
编辑/李阳利 |
|
